Show simple item record

dc.contributor.authorAlpert, Joseph S.
dc.contributor.authorSmith, Roger E.
dc.contributor.authorCarlson, C. Jeffrey
dc.contributor.authorOckene, Ira S.
dc.contributor.authorDexter, Lewis
dc.contributor.authorDalen, James E.
dc.date2022-08-11T08:08:02.000
dc.date.accessioned2022-08-23T15:40:15Z
dc.date.available2022-08-23T15:40:15Z
dc.date.issued1976-09-27
dc.date.submitted2008-03-31
dc.identifier.citation<p>JAMA. 1976 Sep 27;236(13):1477-80.</p>
dc.identifier.issn0098-7484 (Print)
dc.identifier.doi10.1001/jama.1976.03270140029017
dc.identifier.pmid989113
dc.identifier.urihttp://hdl.handle.net/20.500.14038/26357
dc.description.abstractThe hospital course of 144 consecutive patients with pulmonary embolism (PE) demonstrated by pulmonary angiography was reviewed to determine the mortality of patients with treated PE. Twelve patients (8%) died of PE, and eight died of causes other than PE; 124 (86%) survived. Pulmonary embolism was the primary cause of death in only four of the 12 patients who died of PE. Pulmonary embolism contributed to the death of eight other patients, each of whom had associated potentially lethal disease, particularly heart disease. The most important factor affecting mortality was shock due to acute right ventricular failure secondary to massive PE (mortality, 32%). Mortality was not related to magnitude of PE per se; the mortality of patients with massive PE without shock (6%) was the same as that for patients with submassive PE (5%. Patients with PE who survive long enough to have the diagnosis established and appropriate prophylactic therapy begun have an excellent prognosis, unless they have associated severe medical disease.
dc.language.isoen_US
dc.relation<p><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=989113&dopt=Abstract ">Link to article in PubMed</a></p>
dc.relation.urlhttps://doi.org/10.1001/jama.1976.03270140029017
dc.subjectAcute Disease
dc.subjectAdolescent
dc.subjectAdult
dc.subjectAged
dc.subjectHeart Failure
dc.subjectHeart Ventricles
dc.subjectHumans
dc.subjectHypertension, Pulmonary
dc.subjectMiddle Aged
dc.subjectPrognosis
dc.subjectPulmonary Embolism
dc.subjectRecurrence
dc.subjectShock, Cardiogenic
dc.subjectCardiology
dc.subjectCardiovascular Diseases
dc.subjectPathological Conditions, Signs and Symptoms
dc.subjectTherapeutics
dc.titleMortality in patients treated for pulmonary embolism
dc.typeJournal Article
dc.source.journaltitleJAMA : the journal of the American Medical Association
dc.source.volume236
dc.source.issue13
dc.identifier.legacycoverpagehttps://escholarship.umassmed.edu/cardio_pp/37
dc.identifier.contextkey477215
html.description.abstract<p>The hospital course of 144 consecutive patients with pulmonary embolism (PE) demonstrated by pulmonary angiography was reviewed to determine the mortality of patients with treated PE. Twelve patients (8%) died of PE, and eight died of causes other than PE; 124 (86%) survived. Pulmonary embolism was the primary cause of death in only four of the 12 patients who died of PE. Pulmonary embolism contributed to the death of eight other patients, each of whom had associated potentially lethal disease, particularly heart disease. The most important factor affecting mortality was shock due to acute right ventricular failure secondary to massive PE (mortality, 32%). Mortality was not related to magnitude of PE per se; the mortality of patients with massive PE without shock (6%) was the same as that for patients with submassive PE (5%. Patients with PE who survive long enough to have the diagnosis established and appropriate prophylactic therapy begun have an excellent prognosis, unless they have associated severe medical disease.</p>
dc.identifier.submissionpathcardio_pp/37
dc.contributor.departmentDepartment of Medicine, Division of Cardiovascular Medicine
dc.source.pages1477-80


This item appears in the following Collection(s)

Show simple item record